GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Edmond DE Rothschild Holding S.A.

Edmond DE Rothschild Holding S.A. lessened its position in GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 4.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 20,121 shares of the company’s stock after selling 933 shares during the period. Edmond DE Rothschild Holding S.A.’s holdings in GE HealthCare Technologies were worth $1,556,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in GEHC. Janney Capital Management LLC lifted its position in GE HealthCare Technologies by 4.7% in the fourth quarter. Janney Capital Management LLC now owns 3,289 shares of the company’s stock valued at $254,000 after purchasing an additional 149 shares during the period. American National Bank boosted its stake in shares of GE HealthCare Technologies by 25.2% in the fourth quarter. American National Bank now owns 750 shares of the company’s stock valued at $58,000 after buying an additional 151 shares in the last quarter. Chilton Capital Management LLC boosted its stake in shares of GE HealthCare Technologies by 15.4% in the fourth quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock valued at $95,000 after buying an additional 164 shares in the last quarter. Procyon Advisors LLC grew its holdings in GE HealthCare Technologies by 5.2% during the fourth quarter. Procyon Advisors LLC now owns 3,555 shares of the company’s stock worth $275,000 after acquiring an additional 175 shares during the period. Finally, 9258 Wealth Management LLC raised its position in GE HealthCare Technologies by 5.7% in the fourth quarter. 9258 Wealth Management LLC now owns 3,273 shares of the company’s stock worth $253,000 after acquiring an additional 176 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Insider Activity

In other GE HealthCare Technologies news, insider Frank R. Jimenez purchased 1,315 shares of the business’s stock in a transaction that occurred on Wednesday, May 1st. The shares were purchased at an average price of $76.52 per share, for a total transaction of $100,623.80. Following the completion of the acquisition, the insider now owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, insider Frank R. Jimenez bought 1,315 shares of the firm’s stock in a transaction dated Wednesday, May 1st. The stock was bought at an average price of $76.52 per share, with a total value of $100,623.80. Following the completion of the transaction, the insider now directly owns 75,796 shares of the company’s stock, valued at $5,799,909.92. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Jan Makela sold 20,227 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $81.57, for a total value of $1,649,916.39. Following the transaction, the chief executive officer now directly owns 63,348 shares in the company, valued at $5,167,296.36. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. Morgan Stanley increased their price target on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a report on Monday, February 12th. Argus boosted their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, April 1st. Mizuho dropped their price objective on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research note on Wednesday, May 1st. HSBC initiated coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They set a “buy” rating and a $100.00 target price on the stock. Finally, UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and raised their price target for the company from $66.00 to $88.00 in a research report on Monday, February 12th. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $94.80.

Check Out Our Latest Stock Report on GEHC

GE HealthCare Technologies Trading Down 0.4 %

Shares of NASDAQ:GEHC traded down $0.30 during trading on Wednesday, reaching $78.45. The stock had a trading volume of 104,161 shares, compared to its average volume of 3,182,410. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50. The business has a fifty day moving average price of $84.66 and a 200-day moving average price of $80.76. The stock has a market cap of $35.81 billion, a P/E ratio of 23.03, a PEG ratio of 2.87 and a beta of 1.26. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.11.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last announced its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, meeting analysts’ consensus estimates of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The business had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.80 billion. During the same quarter in the previous year, the business earned $0.85 earnings per share. The business’s revenue for the quarter was down 1.2% on a year-over-year basis. As a group, analysts anticipate that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were issued a $0.03 dividend. The ex-dividend date was Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.51%.

GE HealthCare Technologies Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Further Reading

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.